• BSE
  • NSE
    • {{d.cmpname}}
    • {{d.price}}
    • ({{d.PerChg}}%)
Equity | News | Hot Pursuit
Hot Pursuit
Hester Bio soars after agreement with ICAR-IVRI for two vaccines
(12:31, 08 Apr 2021)

In a regulatory filing made during market hours today, the company said that the agreements are for acquiring technologies for the production and commercialisation of classical swine fever vaccine & sheep pox vaccine.

The technologies were developed by ICAR-IVRI and the commercialization of the technologies was facilitated by Agrinnovate India, a company owned by Department of Agricultural, Research & Education (DARE), Ministry of Agriculture, Government of India.

Both the vaccines have been extensively tested by IVRI for safety and potency and have been found to provide 100% protection.

Classical swine fever vaccine has been found to induce protective immunity up to 24 months. Sheep pox vaccine has been found to induce protective immunity up to 48 months.

The vaccines hope to prevent economic losses in swine and sheep farming in India. Hester has targeted to launch both the vaccines commercially in approximately 8 months.

The swine population in India is estimated to be 9.06 million (90 lacs). The sheep population in India is estimated to be 74.26 million (7.42 crores). With a focus on livestock as a source of income, the over-all population of swine and sheep is expected to grow rapidly thereby increasing the demand for vaccines, the company said in a statement.

Hester Biosciences is engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include poultry division and large animal division.

The company's consolidated net profit rose 7.20% to Rs 12.35 crore on a 12.23% increase in net sales to Rs 56.89 crore in Q3 FY21 over Q3 FY20.

Powered by Capital Market - Live News

DB (International) Stock Brokers Limited: SEBI Reg. No.-INZ000179035 / CDSL : IN-DP-CDSL-266-2004 MCX-SX:INE 260643233/21500(CD)
Daga Commodities Private Limited: SEBI Reg. No. INZ000028833
Investor Grievances Email ID: compliance@dbonline.in & investors@dbonline.in
Copyright © 2016 All rights Reserved DB (International) Stock Brokers Ltd.     Designed, Developed and content powered by C-MOTS Infotech( ISO 9001:2015 certified )
"KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."         "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day......................issued in the interest of investors."          "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Attention Investors ::
subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries